BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 29056233)

  • 1. Angiotensin-(1-7) prevents atrial tachycardia induced-heat shock protein 27 expression.
    Wang X; Shangguan W; Li G
    J Electrocardiol; 2018; 51(1):117-120. PubMed ID: 29056233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential role of atrial natriuretic peptide in the effects of Angiotensin-(1-7) in a chronic atrial tachycardia canine model.
    Zhao J; Liu T; Liu E; Li G; Qi L; Li J
    J Renin Angiotensin Aldosterone Syst; 2016; 17(1):1470320315627409. PubMed ID: 27009283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs.
    Liu E; Yang S; Xu Z; Li J; Yang W; Li G
    Regul Pept; 2010 Jun; 162(1-3):73-8. PubMed ID: 20074590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-(1-7) attenuates atrial tachycardia-induced sympathetic nerve remodeling.
    Shangguan W; Shi W; Li G; Wang Y; Li J; Wang X
    J Renin Angiotensin Aldosterone Syst; 2017; 18(3):1470320317729281. PubMed ID: 28877652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-(1-7) prevent atrial tachycardia induced sodium channel remodeling.
    Wang X; Li G
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1349-56. PubMed ID: 24861429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the angiotensin-(1-7)/Mas/PI3K/Akt/nitric oxide axis and the possible role of atrial natriuretic peptide in an acute atrial tachycardia canine model.
    Zhao J; Liu E; Li G; Qi L; Li J; Yang W
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1069-77. PubMed ID: 25143331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs.
    Li Y; Li WM; Gong YT; Li BX; Liu W; Han W; Dong D; Sheng L; Xue JY; Zhang L; Chu S; Yang BF
    Basic Res Cardiol; 2007 May; 102(3):245-56. PubMed ID: 17268887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.
    Liu E; Xu Z; Li J; Yang S; Yang W; Li G
    Int J Cardiol; 2011 Feb; 146(3):364-70. PubMed ID: 19732978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of heat shock response protects the heart against atrial fibrillation.
    Brundel BJ; Shiroshita-Takeshita A; Qi X; Yeh YH; Chartier D; van Gelder IC; Henning RH; Kampinga HH; Nattel S
    Circ Res; 2006 Dec; 99(12):1394-402. PubMed ID: 17110598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor blockade reduces tachycardia-induced atrial adhesion molecule expression.
    Goette A; Bukowska A; Lendeckel U; Erxleben M; Hammwöhner M; Strugala D; Pfeiffenberger J; Röhl FW; Huth C; Ebert MP; Klein HU; Röcken C
    Circulation; 2008 Feb; 117(6):732-42. PubMed ID: 18227384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial overexpression of angiotensin-converting enzyme 2 improves the canine rapid atrial pacing-induced structural and electrical remodeling. Fan, ACE2 improves atrial substrate remodeling.
    Fan J; Zou L; Cui K; Woo K; Du H; Chen S; Ling Z; Zhang Q; Zhang B; Lan X; Su L; Zrenner B; Yin Y
    Basic Res Cardiol; 2015; 110(4):45. PubMed ID: 26143546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irbesartan prevents sodium channel remodeling in a canine model of atrial fibrillation.
    Wang X; Li G
    J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318755269. PubMed ID: 29378480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilostazol Prevents Atrial Structural Remodeling through the MEK/ERK Pathway in a Canine Model of Atrial Tachycardia.
    Zhao Z; Wang Y; Chen Y; Wang X; Li J; Yuan M; Liu T; Li G
    Cardiology; 2016; 135(4):240-248. PubMed ID: 27532517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Low-level Vagus Nerve Stimulation on Cardiac Remodeling in a Rapid Atrial Pacing-induced Canine Model of Atrial Fibrillation.
    Lu Y; Sun J; Zhou X; Zhang L; Ma M; Tang B
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):218-24. PubMed ID: 26727379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation.
    Brundel BJ; Henning RH; Ke L; van Gelder IC; Crijns HJ; Kampinga HH
    J Mol Cell Cardiol; 2006 Sep; 41(3):555-62. PubMed ID: 16876820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probucol attenuates atrial autonomic remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing.
    Gong YT; Li WM; Li Y; Yang SS; Sheng L; Yang N; Shan HB; Xue HJ; Liu W; Yang BF; Dong DL; Li BX
    Chin Med J (Engl); 2009 Jan; 122(1):74-82. PubMed ID: 19187621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.
    Kataoka N; Nishida K; Kinoshita K; Sakamoto T; Nakatani Y; Tsujino Y; Mizumaki K; Inoue H; Kinugawa K
    Heart Vessels; 2016 Dec; 31(12):2053-2060. PubMed ID: 27236656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of atorvastatin on atrial remodeling in a rabbit model of atrial fibrillation produced by rapid atrial pacing.
    Yang Q; Qi X; Dang Y; Li Y; Song X; Hao X
    BMC Cardiovasc Disord; 2016 Jun; 16(1):142. PubMed ID: 27342818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calpain I inhibition prevents pacing-induced structural remodeling for atrial fibrillation in canine].
    Li WM; Xue HJ; Li Y; Zhang L; Gong YT; Sheng L; Chu S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb; 35(2):132-6. PubMed ID: 17445406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amiodarone on electrical and structural remodeling induced in a canine rapid pacing-induced persistent atrial fibrillation model.
    Ashikaga K; Kobayashi T; Kimura M; Owada S; Sasaki S; Iwasa A; Furukawa K; Motomura S; Okumura K
    Eur J Pharmacol; 2006 Apr; 536(1-2):148-53. PubMed ID: 16556442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.